Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Repare Therapeutics Inc RPTX

Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics in Switzerland and the United States. The company uses its proprietary, genome-wide and CRISPR-enabled SNIPRx platform to discover and develop cancer therapies that treat cancers due to mechanisms of genomic instability, including DNA damage repair. It also develops... see more

Current News (NDAQ:RPTX)

No current news is available.

Opinion & Analysis (NDAQ:RPTX)

No current opinion is available.

Bullboard Posts (NDAQ:RPTX)

This stock is being bought out today.

So that you guys should be getting a premium for your shares today anyway
coolfooldumbguy - November 17, 2025

Buy buddy buy.

Otherwise FOMO for you guys out there today anyway
coolfooldumbguy - July 16, 2025

Manipulation

easy to spot... this will be lower then 15 bucks in 3 weeks.
stckapprentice - October 5, 2020

anyone wishing to learn more about RPTX's science

watch the recent PBS science show NOVA     program to watch is called HUMAN NATURE...you will learn about CRISPR and how...
Boggie2 - September 15, 2020

Valuation?????

Does anybody have any ideas about how this stock should be valued.  Such as comparable companies, market potential of technologies...
kaiwolf - June 21, 2020

Podcasts